Christopher P. Lowe - Net Worth and Insider Trading
Christopher P. Lowe Net Worth
The estimated net worth of Christopher P. Lowe is at least $270,375 dollars as of 2024-04-25. Christopher P. Lowe is the Interim CEO of Hansen Medical Inc and owns about 42,500 shares of Hansen Medical Inc (HNSN) stock worth over $169,575. Christopher P. Lowe is the COO & CFO of Quince Therapeutics Inc and owns about 60,000 shares of Quince Therapeutics Inc (QNCX) stock worth over $63,600. Christopher P. Lowe is also the Director of Vincerx Pharma Inc and owns about 40,000 shares of Vincerx Pharma Inc (VINC) stock worth over $37,200. Details can be seen in Christopher P. Lowe's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Christopher P. Lowe has not made any transactions after 2022-08-25 and currently still holds the listed stock(s).
Transaction Summary of Christopher P. Lowe
Christopher P. Lowe Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Christopher P. Lowe owns 6 companies in total, including Quince Therapeutics Inc (QNCX) , Rebus Hldgs Inc (RBSH) , and Hansen Medical Inc (HNSN) among others .
Click here to see the complete history of Christopher P. Lowe’s form 4 insider trades.
Insider Ownership Summary of Christopher P. Lowe
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| QNCX | Quince Therapeutics Inc | 2021-10-05 | Chief Financial Officer |
| RBSH | Rebus Hldgs Inc | 2016-08-03 | director & President and CEO |
| HNSN | Hansen Medical Inc | 2016-07-27 | director & Interim CFO |
| ANTH | Anthera Pharmaceuticals Inc | 2013-05-17 | CFO and Chief Business Officer |
| LSACU | LifeSci Acquisition Corp | 2020-12-23 | director |
| VINC | Vincerx Pharma Inc | 2022-08-25 | director |
Christopher P. Lowe Latest Holdings Summary
Christopher P. Lowe currently owns a total of 3 stocks. Among these stocks, Christopher P. Lowe owns 42,500 shares of Hansen Medical Inc (HNSN) as of May 20, 2014, with a value of $169,575 and a weighting of 62.72%. Christopher P. Lowe owns 60,000 shares of Quince Therapeutics Inc (QNCX) as of October 5, 2021, with a value of $63,600 and a weighting of 23.52%. Christopher P. Lowe also owns 40,000 shares of Vincerx Pharma Inc (VINC) as of August 25, 2022, with a value of $37,200 and a weighting of 13.76%.
Latest Holdings of Christopher P. Lowe
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| HNSN | Hansen Medical Inc | 2014-05-20 | 42,500 | 3.99 | 169,575 |
| QNCX | Quince Therapeutics Inc | 2021-10-05 | 60,000 | 1.06 | 63,600 |
| VINC | Vincerx Pharma Inc | 2022-08-25 | 40,000 | 0.93 | 37,200 |
Holding Weightings of Christopher P. Lowe
Christopher P. Lowe Form 4 Trading Tracker
According to the SEC Form 4 filings, Christopher P. Lowe has made a total of 0 transactions in Hansen Medical Inc (HNSN) over the past 5 years. The most-recent trade in Hansen Medical Inc is the acquisition of 20,000 shares on May 20, 2014, which cost Christopher P. Lowe around $28,800.
According to the SEC Form 4 filings, Christopher P. Lowe has made a total of 2 transactions in Quince Therapeutics Inc (QNCX) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Quince Therapeutics Inc is the sale of 4,963 shares on October 5, 2021, which brought Christopher P. Lowe around $488,856.
According to the SEC Form 4 filings, Christopher P. Lowe has made a total of 2 transactions in Vincerx Pharma Inc (VINC) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Vincerx Pharma Inc is the acquisition of 30,000 shares on August 25, 2022, which cost Christopher P. Lowe around $49,500.
Insider Trading History of Christopher P. Lowe
- 1
Christopher P. Lowe Trading Performance
GuruFocus tracks the stock performance after each of Christopher P. Lowe's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Christopher P. Lowe is -13.65%. GuruFocus also compares Christopher P. Lowe's trading performance to market benchmark return within the same time period. The performance of stocks bought by Christopher P. Lowe within 3 months outperforms 2 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Christopher P. Lowe's insider trading performs compared to the benchmark.
Performance of Christopher P. Lowe
Average Return
-30.59%
Outperforming Transactions
20%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -10.73 | -13.65 | -22.99 | -30.59 | -31.62 | -22.41 |
| Relative Return to S&P 500(%) | -8.12 | -13.39 | -27.81 | -38.1 | -38.69 | -31.51 |
Christopher P. Lowe Ownership Network
Ownership Network List of Christopher P. Lowe
Ownership Network Relation of Christopher P. Lowe
Christopher P. Lowe Owned Company Details
What does Quince Therapeutics Inc do?
Who are the key executives at Quince Therapeutics Inc?
Christopher P. Lowe is the Chief Financial Officer of Quince Therapeutics Inc. Other key executives at Quince Therapeutics Inc include Chief Scientific Officer Guenter Janhofer , President Charles S. Ryan , and director & Chief Executive Officer Dirk Thye .
Quince Therapeutics Inc (QNCX) Insider Trades Summary
Over the past 18 months, Christopher P. Lowe made no insider transaction in Quince Therapeutics Inc (QNCX). Other recent insider transactions involving Quince Therapeutics Inc (QNCX) include a net purchase of 500,436 shares made by David Lamond , a net purchase of 168,000 shares made by Dirk Thye , and a net purchase of 71,762 shares made by Brendan Hannah .
In summary, during the past 3 months, insiders sold 0 shares of Quince Therapeutics Inc (QNCX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,871 shares of Quince Therapeutics Inc (QNCX) were sold and 748,198 shares were bought by its insiders, resulting in a net purchase of 746,327 shares.
Quince Therapeutics Inc (QNCX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Quince Therapeutics Inc Insider Transactions
Christopher P. Lowe Mailing Address
Above is the net worth, insider trading, and ownership report for Christopher P. Lowe. You might contact Christopher P. Lowe via mailing address: 2511 N Loop 1604,, Suite 204, San Antonio Tx 78258.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
